Prevention of Atrial Fibrillation Following Noncardiac Thoracic Surgery
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that the medication amiodarone decreases the incidence of
atrial fibrillation (AF) following non-cardiac open-chest surgery. Their specific aims are
to:
- Determine the effectiveness of amiodarone for the prevention of AF following non-cardiac
open-chest surgery;
- Determine the influence of the prevention of AF following non-cardiac thoracic surgery
on post-surgical duration of stay in the Intensive Care Unit (ICU); post-surgical
duration of stay in a hospital unit that employs cardiac monitoring; and duration of
post-surgical hospital stay; and
- Determine the safety of amiodarone for the prevention of AF following non-cardiac
open-chest surgery.